An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP

The ongoing transmission of Mycobacterium (M.) leprae reflected in a very slow decline in leprosy incidence, forces us to be innovative and conduct cutting-edge research. Single dose rifampicin (SDR) as post-exposure prophylaxis (PEP) for contacts of leprosy patients, reduces their risk to develop l...

Full description

Saved in:

Bibliographic Details
Published in:	BMC infectious diseases Vol. 18; no. 1; pp. 506 - 8
Main Authors:	Mieras, Liesbeth F, Taal, Anna T, van Brakel, Wim H, Cambau, Emmanuelle, Saunderson, Paul R, Smith, W Cairns S, Prakoeswa, Cita Rosita S, Astari, Linda, Scollard, David M, do Nascimento, Dejair Caitano, Grosset, Jacques, Kar, Hemanta K, Izumi, Shinzo, Gillini, Laura, Virmond, Marcos C L, Sturkenboom, Marieke G G
Format:	Journal Article
Language:	English
Published:	London BioMed Central 05.10.2018 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Adults Analysis Anti-Bacterial Agents - therapeutic use Antibiotics Care and treatment Chemoprophylaxis Children Clarithromycin Clarithromycin - therapeutic use Debate Dermatology Dosage and administration Drug dosages Drug resistance Exposure Fluoroquinolones - therapeutic use Humans Incidence Infectious Diseases Internal Medicine Intervention study Leprosy Leprosy - drug therapy Leprosy - microbiology Leprosy - prevention & control Medical Microbiology Medicine Medicine & Public Health Moxifloxacin Multidrug resistant organisms Netherlands Parasitology Pharmacology Post-exposure prophylaxis Post-Exposure Prophylaxis - methods Prevention Prophylaxis Public health Reduction Rifampicin Rifampin Rifampin - therapeutic use Signs and symptoms Treatment outcome Tropical Medicine Tuberculosis Tuberculosis and other mycobacterial diseases Weight Netherlands Nepal India Chemoprophylaxis Intervention study Clarithromycin Rifampicin Leprosy Post-exposure prophylaxis Moxifloxacin
ISSN:	1471-2334, 1471-2334
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!